Celularity - Class A (CELU) closed at $0.57 on November 17, 2026, down 7.7% from the previous close, on volume of 229,215 shares (30-day average 145,471).
Data as of November 17, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Covered Put | 20-Nov-26 1.5 P +89,200 Stock | 892 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days
Celularity Reports Delay in Its Quarterly SEC Filing
TipRanks (Mon, 16-Nov 7:43 PM ET)
Business Wire (Thu, 29-Oct 9:00 AM ET)
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
Globe Newswire (Thu, 22-Oct 8:00 AM ET)
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
Globe Newswire (Wed, 30-Sep 11:57 AM ET)
Celularity Announces Naveen Jain to Join Board of Directors
Globe Newswire (Tue, 29-Sep 8:30 AM ET)
Globe Newswire (Thu, 24-Sep 9:15 AM ET)
Business Wire (Thu, 27-Aug 9:00 AM ET)
Celularity Provides Update Regarding Nasdaq Listing Compliance
Globe Newswire (Tue, 25-Aug 7:59 PM ET)
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Celularity - Class A trades on the NASDAQ stock market under the symbol CELU.
As of November 18, 2026, CELU stock price declined to $0.53 with 171,076 million shares trading.
CELU has a beta of 1.59, meaning it tends to be more sensitive to market movements. CELU has a correlation of 0.03 to the broad based SPY ETF.
CELU has a market cap of $17.20 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELU traded as high as $7.97 and as low as $.53.
The top ETF exchange traded funds that CELU belongs to (by Net Assets): VTI, VXF.
CELU has underperformed the market in the last year with a price return of -65.1% while the SPY ETF gained +11.2%. CELU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.9% and -35.1%, respectively, while the SPY returned -4.9% and -2.9%, respectively.
CELU support price is $.51 and resistance is $.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELU shares will trade within this expected range on the day.